Daewoong Pharmaceutical Indonesia (DPI) operates state-of-the-art manufacturing facilities, strategically positioned to support the growth of Indonesia’s pharmaceutical and biotechnology industry. Our plants specialize in stem cell therapies and biopharmaceuticals, ensuring high-quality production that meets the evolving needs of the Indonesian healthcare system.
In addition to our expertise in biopharmaceuticals, DPI is actively expanding its business in the cosmeceutical sector through ODM (Original Design Manufacturing) services, offering small-scale production that handles every aspect of product planning, development, production, and manufacturing to provide tailored solutions for the skincare industry.